Cardiology Letters 2017, 26(1):47-51
Pulmonary hypertension associated with systemic sclerosis - too many grey zones
- 1 Centrum pre pľúcnu hypertenziu, Oddelenie zlyhávania a transplantácie srdca, Národný ústav srdcových a cievnych chorôb, Bratislava
- 2 Národný ústav reumatických chorôb, Piešťany
- 3 Lekárská fakulta Univerzita Komenského v Bratislave, Slovenská republika
Background: Pulmonary arterial hypertension (PAH) is an important cause of death in systemic sclerosis (SSc). Diagnosis of PAH is based on strict arbitrary hemodynamic criteria. Borderline conditions with pulmonary artery pressures in grey zones are not rare in SSc patients. The diagnostic, prognostic, and therapeutic significance of these findings has not been satisfactorily clarified. Correct diagnostic conclusion has a major impact on appropriate treatment decisions.
Aim: To describe the results of diagnostic work-up in patients with SSc in a single centre referred for clinical or echocardiographic suspicion of PAH with special regard to borderline conditions.
Patients and methods: 104 patients (pts) with SSc were referred by rheumatologists to a PAH centre. Cardio vascular examination including echocardiography was performed. 57 pts (7 men) with suspicion of PAH underwent a complete PAH diagnostic algorithm including right heart catheterization. Median age was 61 (39-80 years). Estimated systolic pulmonary artery pressure <50 mm Hg or no tricuspid regurgitation was detected in 15 pts: however, catheterization was performed due to unexplained dyspnea.
Results: PAH was diagnosed in 23 (40%) pts who underwent right heart catheterization. Group II pulmonary hypertension due to left ventricular diastolic dysfunction was diagnosed in 12 (21%) pts. In 22 (39%) patients, no pulmonary hypertension was detected. Mean pulmonary arterial pressure of 21-24 mm Hg was present in 7 (32%) pts who did not meet the pulmonary hypertension criteria. Pulmonary wedge pressure of 12 to 15 mm Hg was present in 7 (30%) PAH patients. Of 15 pts with estimated systolic pulmonary pressure of <50 mm Hg or no tricuspid regurgitation on echo, 2 (13%) were diagnosed with PAH and 5 (33%) with group II pulmonary hypertension. Complications of right heart catheterization were rare.
Conclusion: Prevalence of PAH in a risk group of patients with SSc referred for clinical or echocardiographic suspicion of PAH is relatively high. However, borderline hemodynamic conditions in patients with dyspnea in context of SSc are frequent. Borderline situations require a correct interpretation and detailed evaluation as treatment strategy and patient outcome depend on a thorough diagnosis.
Keywords: pulmonary hypertension; systemic sclerosis; borderline pressures
Published: January 1, 2017 Show citation
References
- Lukáč J. Systémová skleróza. In: Ďuriš I, Hulín I, Bernadič M (Eds.). Princípy internej medicíny 2. Bratislava: Slovak Academic Press; 2001:1439-1444.
- Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66: 940-944.
Go to original source... - Galie N Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2015;46(4):903-975.
Go to original source... - Humbert M, Yaïci A, de Groote P, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum. 2011;63(11):3522-3530.
Go to original source... - Humbert M, Morrell N, Archer S, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:S13-S24.
Go to original source... - Condliffe R, Howard LS. Connective tissue disease-associated pulmonary arterial hypertension. F1000Prime Reports 2015,7:06 (doi:10.12703/P7-06)
Go to original source... - Thakkar V, Stevens MW, Prior D, et al. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Res Ther. 2012;14:R143-153.
Go to original source... - Coghlan JG, Denton CP, Grünig E, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT Ann Rheum Dis. 2014;73(7):1340-1349.
Go to original source... - Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. Am Coll Cardiol. 2013 Dec;62(25 Suppl):D42-50.
Go to original source... - Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009;34:888-894.
Go to original source... - Robbins IM, Hemnes AR, Pugh ME, et al. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail 2014;7(1):116-122.
Go to original source... - Lesný P, Luknár M, Varga I, et al. Exercise hemodynamics can predict otherwise unpredictable left heart failure in patients referred due to suspicion of pulmonary arterial hypertension. J Heart Lung Transpl 2012;31:S69
Go to original source... - Walker UA, Tyndall A, Czirják L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66:754-763.
Go to original source... - Morales-Cárdenas A, Camila Pérez-Madrid C, Arias L, et al. Pulmonary involvement in systemic sclerosis. Autoimmun Rev. 2016 Nov;15(11):1094-1108.
Go to original source... - Cao Z, Mathai SC, Hummers LK, et al. Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosis Pulm Circ 2016;6(4):545-550.
Go to original source...

